Global Multiple Sclerosis Therapies Market to Grow at 4.61% During 2022-2027, Impelled by Increasing Prevalence

December 06, 2021

According to the latest report by IMARC Group, titled "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global multiple sclerosis therapies market reached a value of US$ 24.5 Billion in 2021. Multiple sclerosis (MS) therapies refer to various drugs and treatments that help modify the course of the disease, speed up recovery from attacks, and manage symptoms in patients. Some commonly used MS therapies include antidepressants, immunosuppressants, physical therapy, muscle relaxants, and oral, infused and injectable medicines. They aid in treating specific MS symptoms, reducing the frequency of relapses, and controlling the heart rate and blood pressure of patients. Presently, there is no cure for MS; however, doctors can determine the most suitable therapies that cause the least side effects and help the patient manage the disease. 

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Multiple Sclerosis Therapies Market Trends:

The rising prevalence of relapsing-remitting MS (RRMS) and secondary-progressive MS (SPMS) represents the primary factor driving the global market. Besides this, several initiatives undertaken by government and non-government organizations to spread awareness regarding MS symptoms and available treatment options are catalyzing the market growth. Additionally, the escalating demand for novel potent and rapid-acting drugs is encouraging manufacturers to develop advanced product variants with high efficacy, low dosage requirements and minimal side effects. This, in confluence with the heavy investments by key players in the drug development process, is propelling the market growth. Furthermore, the launch of innovative monoclonal bodies, immunosuppressants, immunomodulators, and interferons to effectively treat MS symptoms is accelerating product adoption rates. Other factors, including recent technological advancements, ongoing research and development (R&D) activities, improving healthcare infrastructure and increasing focus of pharmaceutical companies on pipeline drugs, are creating a favorable market outlook. Looking forward, the market is anticipated to grow at a CAGR of 4.61% during the forecast period (2022-2027). 

Market Summary:

  • Based on the drug, the market has been classified as immunomodulators (Copaxone, Avonex/Plegridy, Gilneya, Tysabri, Betaseron/Extavia, Tecifidera, Rebif and Ampyra) and immunosuppressants (Aubagio, Lemtrada, Ocrelizumab, and Zinbryta). 
  • The market has been bifurcated based on the drug type into biologic and small molecule drugs.
  • Based on the route of administration, the market has been divided into oral, injectable, and intravenous. 
  • Based on the distribution channel, the market has been segmented into hospital, retail and online pharmacies. 
  • Region-wise, the market has been segregated into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being AbbVie Inc., Bayer AG, Biogen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd. (Roche Holding AG), GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, Sanofi S.A., and Teva Pharmaceutical Industries Ltd.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Multiple Sclerosis Therapies Market to Grow at 4.61% During 2022-2027, Impelled by Increasing Prevalence
Select Licence Type

Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More